These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9261939)

  • 21. [Immunological effects of live attenuated hepatitis A vaccine].
    Cheng NL
    Zhonghua Yi Xue Za Zhi; 1992 Oct; 72(10):581-3, 638. PubMed ID: 1338501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis A vaccines.
    Wkly Epidemiol Rec; 2000 Feb; 75(5):38-44. PubMed ID: 10693358
    [No Abstract]   [Full Text] [Related]  

  • 23. Live attenuated hepatitis A vaccines developed in China.
    Xu ZY; Wang XY
    Hum Vaccin Immunother; 2014; 10(3):659-66. PubMed ID: 24280971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Protection of adolescents against hepatitis A].
    Puntarić D; Baklaić Z; Ljubicíc M; Vodopija I
    Lijec Vjesn; 1996 Oct; 118(10):241-3. PubMed ID: 9132523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings.
    André FE; D'Hondt E; Delem A; Safary A
    Vaccine; 1992; 10 Suppl 1():S160-8. PubMed ID: 1335652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks.
    Just M; Berger R; Dreschsler H; Brantschen S; Glück R
    Vaccine; 1992; 10(11):737-9. PubMed ID: 1441728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans.
    Mao JS; Dong DX; Zhang HY; Chen NL; Zhang XY; Huang HY; Xie RY; Zhou TJ; Wan ZJ; Wang YZ
    J Infect Dis; 1989 Apr; 159(4):621-4. PubMed ID: 2538518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity trial of inactivated hepatitis A virus vaccine in human volunteers.
    Kusov YuYu ; Elbert LB; Nelga IV; Grishina GK; Dunaevski OA; Kharin NV; Maslov YuN ; Drozdov SG; Balayan MS
    Vaccine; 1991 Aug; 9(8):540-1. PubMed ID: 1663301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children.
    Castillo de Febres O; Chacon de Petrola M; Casanova de Escalona L; Naveda O; Naveda M; Estopinan M; Bordones G; Zambrano B; Garcia A; Dumas R
    Vaccine; 1999 Nov; 18(7-8):656-64. PubMed ID: 10547425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against hepatitis A by an inactivated vaccine.
    Innis BL; Snitbhan R; Kunasol P; Laorakpongse T; Poopatanakool W; Kozik CA; Suntayakorn S; Suknuntapong T; Safary A; Tang DB
    JAMA; 1994 May; 271(17):1328-34. PubMed ID: 8158817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine.
    Theilmann L; Kallinowski B; Gmelin K; Hofmann F; Scheiermann N; Wohland B; Stickl H; Maiwald H; Moriabadi FK; Bock HL
    Vaccine; 1992; 10 Suppl 1():S132-4. PubMed ID: 1335644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children.
    Balcarek KB; Bagley MR; Pass RF; Schiff ER; Krause DS
    J Infect Dis; 1995 Mar; 171 Suppl 1():S70-2. PubMed ID: 7876652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunogenicity and tolerance of a combined hepatitis A/B vaccine. Preliminary results with a candidate vaccine].
    Kallinowski B; Bock HL; Clemens R; Theilmann L
    Dtsch Med Wochenschr; 1995 Oct; 120(42):1426-9. PubMed ID: 7555671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Horizontal transmission of live attenuated hepatitis A vaccine virus].
    Huang X; Cao Y; Tan S
    Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(8):465-7. PubMed ID: 11798919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis A vaccination by intracutaneous low dose administration: a less expensive alternative.
    Carlsson U; Brudin L; Eliasson I; Hansson BG
    Scand J Infect Dis; 1996; 28(5):435-8. PubMed ID: 8953668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of hepatitis A vaccination schedules on immune response.
    Tilzey AJ; Palmer SJ; Barrow S; Perry KR; Tyrell H; Safary A; Banatvala JE
    Vaccine; 1992; 10 Suppl 1():S121-3. PubMed ID: 1335640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing live attenuated and inactivated hepatitis A vaccines: an immunogenicity study after one single dose.
    Zheng H; Chen Y; Wang F; Gong X; Wu Z; Miao N; Zhang X; Li H; Chen C; Hou X; Cui F; Wang H
    Vaccine; 2011 Nov; 29(48):9098-103. PubMed ID: 21875638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Safety observation of attenuated live hepatitis B vaccine (H2 strain) in humans].
    Zhang S
    Zhonghua Yi Xue Za Zhi; 1990 Dec; 70(12):682-4, 48. PubMed ID: 1963372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies.
    Victor JC; Surdina TY; Suleimenova SZ; Favorov MO; Bell BP; Monto AS
    Am J Epidemiol; 2006 Feb; 163(3):204-10. PubMed ID: 16339053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on re-immunization with live attenuated hepatitis A vaccine].
    Liu Y; Xu Z; Ouyang P
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 May; 32(3):162-4. PubMed ID: 10322791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.